Author:
Wang Yaning,Bhattaram A. Venkatesh,Jadhav Pravin R.,Lesko Lawrence J.,Madabushi Rajanikanth,Powell J. Robert,Qiu Wei,Sun He,Yim Dong S.,Zheng Jenny J.,Gobburu Jogarao V. S.
Subject
Pharmacology (medical),Pharmacology
Reference20 articles.
1. Food and Drug Administration Innovation or stagnation: challenges and opportunity on the critical path to new medical products March 2004 http:www.fda.govocinitiativescriticalpathwhitepaper.html
2. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER) October 2003 http:www.fda.govohrmsdocketsac03briefing3998B101Topic201-Part20A.pdf
3. Impact of pharmacometrics on drug approvals and labeling decisions: survey of 42 new drug applications;Bhattaram;AAPS J.,2005
4. Impact of pharmacokinetic review on new drug approval and labeling decisions-a survey of 31 new drug applications submitted between 2005 and 2006;Bhattaram;Clin Pharmacol Ther.,2007
5. Paving the critical path: how can clinical pharmacology help achieve the vision?;Lesko;Clin Pharmacol Ther.,2007
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献